Dr. Daniel X. Yang, MD

Dr. Yang practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Yang's NPI, 1750818928, was assigned on May 17, 2017. Dr. Yang graduated from Yale School of Medicine in 2017. Dr. Yang holds Texas license T7398.

Dr. Yang's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Yang's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Yang to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yang practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Yang's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Yang is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Yang's licenses on file in 2 states: Texas and Connecticut.

Dmand AI lists bladder cancer radiation, bone cancer radiation and prostate cancer radiation among the conditions Dr. Yang treats.

CMS data shows 1,636 Medicare services from Dr. Yang across 14 procedure codes in 2024, for 140 Medicare patients. Medicare paid $108,483 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 140 Medicare patients who saw Dr. Yang in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yang's median patient age at 71, with 5% women.

In 2024, Dr. Yang wrote 174 Medicare Part D claims for 77 patients. 99% of them were for generic drugs. CMS names the drug for 134 of them, across 3 drugs with 11 or more claims each, at $2,168 in total drug cost. In 2023, CMS named 88 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Yang for performance year 2024, reported as part of a group. Dr. Yang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yang as offering telehealth.

Dmand AI links 22 papers to Dr. Yang, published from 2013 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Analgesics, Opioid, Cancer Survivors and Communication. Dr. Yang has published most often in Cureus. Dr. Yang's most frequent co-authors are Vikram Jairam, MD, Raquibul Hannan, MD, PhD and Antonio Marcilio Padula Omuro, MD.

CMS Open Payments shows 12 general payments to Dr. Yang from 8 drug and device companies from 2023 to 2025. Travel and lodging make up the largest share, 62% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $1,565.

Dr. Yang graduated from Yale School of Medicine in 2017.

Dr. Yang is in network with 18 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.